How Defensin Peptides Drive Virus Evolution: Adenovirus Mutates to Escape Gut Immune Defense | Research

The takeaway

When exposed to human defensin peptides, adenovirus rapidly evolved mutations in its capsid protein, revealing that these innate immune peptides act as a selective force shaping viral evolution.

Defensins drive viral evolution
Adenovirus rapidly evolved hexon mutations when exposed to human defensin, demonstrating that antimicrobial peptides are a selective force shaping virus populations

What the researchers found

When a defensin-sensitive adenovirus serotype was passaged in the presence of human defensin, mutations accumulated in the hexon protein — the major capsid protein — rather than in the vertex proteins previously identified as important for defensin antiviral activity.

Infection and biochemical assays revealed that defensins interact with all major capsid proteins, creating a balance between two opposing effects: increased cell binding (which could enhance infection) and a downstream block in intracellular trafficking (which inhibits infection). The net outcome of infection depends on which effect dominates. This demonstrates that defensins impose genuine selective pressure during fecal-oral transmission, driving viral evolution and explaining why closely related viruses can have very different infection outcomes.

Why it matters

This study reveals that the antimicrobial peptides in your gut don't just kill pathogens — they shape how viruses evolve. This is a new dimension of the evolutionary arms race between hosts and pathogens. Understanding how defensins drive viral evolution could explain why certain virus strains are more infectious than others and could inform the development of antiviral strategies that are harder for viruses to evolve resistance against.

How the study worked

Laboratory evolution experiment. Researchers passaged a defensin-sensitive adenovirus serotype in the presence of a human enteric alpha-defensin over multiple generations and sequenced the resulting viral genomes to identify adaptive mutations. They then used infection assays and biochemical analyses to characterize how the mutations affected defensin-virus interactions, cell binding, and intracellular trafficking in A549 cells.

What this study cannot tell us

The study was conducted in vitro with a single adenovirus serotype and one human defensin — the findings may not generalize to all virus-defensin interactions. Laboratory evolution under controlled conditions may not fully replicate the complex selective pressures during natural fecal-oral transmission. The mechanism was studied in A549 lung cancer cells, not intestinal epithelial cells where defensins naturally act. The balance between cell binding enhancement and trafficking block may differ across cell types.

How to read the evidence

This is a well-designed preclinical laboratory study using experimental evolution, sequencing, and functional assays. It provides strong mechanistic evidence for defensin-driven viral evolution, though the findings are limited to one virus-defensin pair in vitro.

When this study was published

Published in 2020 in PLoS Pathogens, this study introduced a novel concept in host-pathogen coevolution. The finding that antimicrobial peptides drive viral evolution continues to influence research in this field.

The bigger picture

Defensins are among the oldest and most conserved components of innate immunity, yet their role in shaping pathogen evolution has been largely overlooked. This study opens a new chapter in host-pathogen coevolution by showing that antimicrobial peptides aren't just static defenses — they're active evolutionary forces that drive microbial diversification. This concept extends beyond adenovirus to any pathogen that encounters defensins during transmission, potentially explaining diversity patterns across many viral families.

Questions still open

Do other enteric viruses (norovirus, rotavirus) show similar defensin-driven evolutionary patterns?
Could understanding defensin-driven evolution help predict which viral strains will emerge as more infectious?
How do the multiple defensin types in the human gut collectively shape viral evolution during natural transmission?

Common questions

What are alpha-defensins and where are they found?

Alpha-defensins are small antimicrobial peptides — short chains of amino acids that can kill bacteria, viruses, and fungi. They're produced in large quantities in the small intestine (by specialized cells called Paneth cells) and by neutrophils (white blood cells). In the gut, they act as a first line of defense against pathogens that enter through food and water, making them one of your body's most important innate immune barriers.

How can a defense mechanism also help viruses?

It's a surprising twist of evolution. Defensins normally kill viruses by disrupting their ability to infect cells. But this study found that defensins interact with multiple parts of the virus capsid, and some interactions actually increase the virus's ability to bind to cells. Over many generations, viruses can evolve mutations that tip the balance in their favor — keeping the enhanced cell binding while escaping the trafficking block. It's a molecular arms race where the immune system's weapons become the virus's evolutionary training ground.

Read the original research

Defensin-driven viral evolution.

PLoS pathogens, 16(11), e1009018

View on PubMed ↗Publisher’s paper ↗

Citation

Diaz, Karina; Hu, Ciara T; Sul, Youngmee; Bromme, Beth A; Myers, Nicolle D; Skorohodova, Ksenia V; Gounder, Anshu P; Smith, Jason G. (2020). Defensin-driven viral evolution.. PLoS pathogens, 16(11), e1009018. https://doi.org/10.1371/journal.ppat.1009018